Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × raltitrexed × 90 days × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Specimen Handling 115 pembrolizumab 110 Cyclophosphamide 96 Magnetic Resonance Spectroscopy 90 Biopsy 87 fludarabine 73 Nivolumab 52 venetoclax 48 Radiotherapy 33 Cetuximab 32 Carboplatin 32 fludarabine phosphate 31 Bevacizumab 31 Paclitaxel 30 Gemcitabine 30 Cisplatin 29 Fluorouracil 28 Azacitidine 27 atezolizumab 26 durvalumab 24 Ipilimumab 24 Dexamethasone 24 Cytarabine 24 Lenalidomide 23 Injections 23 Temozolomide 22 Radiosurgery 22 Oxaliplatin 21 Irinotecan 21 Leucovorin 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04761185 2026-02-25

Raltitrexed in HIPEC

Fudan University

Phase 1 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡